Region in Reform? Access Pains and Gains in Latin America
CMED: The ‘Curupira’ of Brazil’s Pharma Market
The Trouble with Pharma Partnerships ... And How to Fix Them
Reducing the Risk of Noncompliance
When You Need Experts, Use Them
Pricing Pressures and Policy Changes
Not Your Typical Pharma Dateline
Market Access: Current and Future States
Market Access: A UK Perspective
Country Report: Singapore
Pharmaceutical Executive, February 2017 Issue (PDF)
Obstacles to Europe's HTA ambitions